Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophie K. Elvig
Observed name:
Elvig, Sophie K
Institutions:
University of Maryland, Baltimore,
National Institutes of Health,
National Institute on Drug Abuse
Observed institutions:
University of Maryland, Baltimore,
National Institutes of Health,
National Institute on Drug Abuse,
University of Colorado Boulder
ORCID:
0000-0002-1049-1523
Observed ORCID:
0000-0002-1049-1523
OpenAlex ID:
A5071453077
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
2023
·
Vicky Chuong
, Mehdi Farokhnia
, et al.
·
JCI Insight
·
239
PDF
Tolerance to alcohol: A critical yet understudied factor in alcohol addiction
2021
·
Sophie K. Elvig
, M. Adrienne McGinn
, et al.
·
Pharmacology Biochemistry and Behavior
·
99
Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents
2021
·
Corinde E. Wiers
, Leandro F. Vendruscolo
, et al.
·
Science Advances
·
77
Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
2022
·
Mehdi Farokhnia
, Christopher T. Rentsch
, et al.
·
Molecular Psychiatry
·
43
PDF
Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
2021
·
Vikrant R. Mahajan
, Sophie K. Elvig
, et al.
·
Frontiers in Psychiatry
·
36
PDF
Oral prescription opioid‐seeking behavior in male and female mice
2019
·
Alysabeth G. Phillips
, Dillon J. McGovern
, et al.
·
Addiction Biology
·
31
PDF
A ketogenic diet reduces hepatic alcohol metabolism and alcohol consumption in rats
2026
·
Sophie K. Elvig
, Adrienne McGinn
, et al.
·
Neuropsychopharmacology
·
2
Non-canonical subthalamic nucleus projections regulate motor variability
2026
·
Oluwatomiwa A. Oladunni
, Sophie K. Elvig
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Neurobehavioral effects of focused ultrasound-mediated blood-brain barrier opening
2026
·
Sophie K. Elvig
, Alexandra A. Seas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Converging Evidence from Rodent and Human Studies on the Role of Spironolactone as a Potential Pharmacotherapy for Alcohol Use Disorder
2023
·
Mehdi Farokhnia
, Christopher T. Rentsch
, et al.
·
Alcohol
Show more works
View as search
Works count:
11
Citation count:
527
H-index:
6
I10-index:
6
Year
Topic
Type